Spring til hovednavigation Spring til søgning Spring til hovedindhold

Real World SB4 (Etanercept Biosimilar) Use in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

  • Alexander Egeberg
  • , Giampiero Girolomoni
  • , Steven R Feldman
  • , Marc-Alexander Radtke
  • , José Manuel Carrascosa
  • , Jeehoon Ghil
  • , Jung Won Keum
  • , Jieun Lee
  • , Hyoryeong Seo
5 Citationer (Scopus)

Abstract

Psoriasis is a chronic, systemic, inflammatory skin disease with a risk of comorbidities and a potential high impact on patients’ quality of life.

OriginalsprogEngelsk
TidsskriftJournal of drugs in dermatology : JDD
Vol/bind19
Udgave nummer3
Sider (fra-til)316-318
Antal sider3
ISSN1545-9616
StatusUdgivet - 1 mar. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Real World SB4 (Etanercept Biosimilar) Use in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR)'. Sammen danner de et unikt fingeraftryk.

Citationsformater